Search
Conmed Corp
CNMDAdd to Watchlist
33.830USD
+1.070+3.27%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.02BMarket Cap
19.08P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.27%
5 Days
-4.44%
1 Month
-2.37%
6 Months
-16.67%
Year to Date
-16.67%
1 Year
-37.43%
Key Figures
33.310Open
34.080High
437.00KVolume
19.08P/E TTM
7.11P/E Dynamic
0.400Dividend TTM
1.45%Turnover Ratio
32.760Prev. Close
32.980Low
8.58MTurnover
7.70P/E Static
1.00P/B
1.18%Div Yield TTM
2.38%ROA
60.35052wk High
1.45Volume Ratio
132.42MNet Profit
30.14MShares
1.7733EPS TTM
0.93Beta
5.50%ROE
33.21052wk Low
3.36%Amplitude
57.86%Gross Margin
1.02BMarket Cap
-0.39Reward/Risk
2.36%Risk Rate
TradingKey Stock Score of Conmed Corp
Currency: USD Updated: 2026-07-01Key Insights
Conmed Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 61 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 39.50.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Conmed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Conmed Corp Highlights
StrengthsRisks
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.
Fairly Valued
The company’s latest PE is 18.47, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 34.51M shares, decreasing 16.95% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 21.68K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.32.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
39.500
Target Price
+14.79%
Upside Space
Conmed Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Conmed Corp Info
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Ticker SymbolCNMD
CompanyConmed Corp
CEOBeyer (Patrick J)
Websitehttps://www.conmed.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.76%
+3.40%
+1.10%
-2.09%
+3.50%Popular Instruments
FAQs
What is the current price of Conmed Corp (CNMD)?
The current price of Conmed Corp (CNMD) is 32.77.
What is the symbol of Conmed Corp?
The ticker symbol of Conmed Corp is CNMD.
What is the 52-week high of Conmed Corp?
The 52-week high of Conmed Corp is 60.35.
What is the 52-week low of Conmed Corp?
The 52-week low of Conmed Corp is 33.21.
What is the market capitalization of Conmed Corp?
The market capitalization of Conmed Corp is 986.38M.
Is Conmed Corp (CNMD) currently rated as Buy, Hold, or Sell?
According to analysts, Conmed Corp (CNMD) has an overall rating of signal_hold, with a price target of 39.50.
What is the Earnings Per Share (EPS TTM) of Conmed Corp (CNMD)?
The Earnings Per Share (EPS TTM) of Conmed Corp (CNMD) is 1.52.